118 related articles for article (PubMed ID: 8182373)
1. Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system.
Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Marshall NJ
J Endocrinol; 1994 Mar; 140(3):445-53. PubMed ID: 8182373
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of growth hormone bioactivity by zinc in the eluted stain assay system.
Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Weir T; Marshall NJ
Endocrinology; 1993 Dec; 133(6):2803-8. PubMed ID: 8243307
[TBL] [Abstract][Full Text] [Related]
3. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.
Dattani MT; Hindmarsh PC; Pringle PJ; Brook CG; Marshall NJ
J Clin Endocrinol Metab; 1995 Sep; 80(9):2675-83. PubMed ID: 7545696
[TBL] [Abstract][Full Text] [Related]
4. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.
Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P
Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.
Bozzola M; Zecca M; Locatelli F; Radetti G; Pagani S; Autelli M; Tatò L; Chatelain P
J Endocrinol Invest; 1998 Dec; 21(11):765-70. PubMed ID: 9972677
[TBL] [Abstract][Full Text] [Related]
6. G120R, a human growth hormone antagonist, shows zinc-dependent agonist and antagonist activity on Nb2 cells.
Dattani MT; Hindmarsh PC; Brook CG; Robinson IC; Kopchick JJ; Marshall NJ
J Biol Chem; 1995 Apr; 270(16):9222-6. PubMed ID: 7721840
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
8. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats.
Tzanela M; Wagner C; Tannenbaum GS
Endocrinology; 1997 Dec; 138(12):5316-24. PubMed ID: 9389516
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein.
Lim L; Spencer SA; McKay P; Waters MJ
Endocrinology; 1990 Sep; 127(3):1287-91. PubMed ID: 2387255
[TBL] [Abstract][Full Text] [Related]
11. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.
Nickel BE; Kardami E; Cattini PA
Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutagenesis of hGH at the 54-74 loop selectively modifies its lactogenic receptor-mediated biological activity.
Sakal E; Tchelet A; Uchida E; Shimokawa S; Nishikawa S; Hayakawa T; Krivi GG; Gertler A
Mol Cell Endocrinol; 1993 Nov; 97(1-2):129-34. PubMed ID: 8143895
[TBL] [Abstract][Full Text] [Related]
13. The development of an eluted stain bioassay (ESTA) for human growth hormone.
Ealey PA; Yateman ME; Sandhu R; Dattani MT; Hassan MK; Holt SJ; Marshall NJ
Growth Regul; 1995 Mar; 5(1):36-44. PubMed ID: 7538369
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
[TBL] [Abstract][Full Text] [Related]
15. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat.
Clark RG; Mortensen DL; Carlsson LM; Spencer SA; McKay P; Mulkerrin M; Moore J; Cunningham BC
Endocrinology; 1996 Oct; 137(10):4308-15. PubMed ID: 8828490
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells. Selective enhancement by anti-mouse IgG.
Elberg G; Kelly PA; Djiane J; Binder L; Gertler A
J Biol Chem; 1990 Sep; 265(25):14770-6. PubMed ID: 2394695
[TBL] [Abstract][Full Text] [Related]
18. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes.
Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A
Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of in vitro and in vivo modulation of lactogenic and somatotropic receptors by native human growth hormone and its modified analog prepared by recombinant deoxyribonucleic acid technology.
Ashkenazi A; Vogel T; Barash I; Hadari D; Levanon A; Gorecki M; Gertler A
Endocrinology; 1987 Jul; 121(1):414-9. PubMed ID: 3595523
[TBL] [Abstract][Full Text] [Related]
20. Influence of Mg2+ on detection of somatogenic and lactogenic components of growth-hormone-binding protein in mammalian sera.
Amit T; Hochberg Z; Barkey RJ
Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):345-9. PubMed ID: 8343113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
